TITLE

Neuroendocrine differentiation in castration-resistant prostate cancer: A case report

AUTHOR(S)
PRIFTAKIS, DIMITRIOS; KRITIKOS, NIKOLAOS; KLEANTHOUS, STEFANOS; BAZIOTIS, NIKOLAOS; STAVRINIDES, STAVROS
PUB. DATE
November 2015
SOURCE
Molecular & Clinical Oncology;Nov/Dec2015, Vol. 3 Issue 6, p1392
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The most common type of prostate cancer is acinar adenocarcinoma, which is androgen-dependent and, therefore, treated with chemical or surgical castration and androgen receptor inhibition. However, the disease usually progresses to castration-resistant prostate cancer (CRPC). A neuroendocrine pattern is frequently observed in the cellular composition of CRPC, which is considered to emerge as an effect of androgen deprivation therapy. This is the case report of a 69-year-old patient with prostate adenocarcinoma, who, after an initial period of disease control with radiotherapy and antiandrogens, was diagnosed with CRPC with high levels of prostate-specific antigen (PSA), unresponsive to androgen inhibition, with accompanying lung and osseous metastases. Bronchial biopsy of the lung metastasis revealed infiltration by non-small-cell adenocarcinoma of prostatic origin with neuroendocrine characteristics. On somatostatin receptor scintigraphy with 99mTc-octreotide, there was high uptake by almost all known lung and osseous metastases. The patient was subsequently treated with a combination of docetaxel and octreotide, and a partial response was observed 6 months later, with reduction of the PSA level and the size of the lung metastasis. The aim of the present study was to provide a clinical example of the previously demonstrated, in vitro and in vivo, synergistic antitumor activities of docetaxel and octreotide in cases of CRPC selected by means of histological confirmation of their neuroendocrine nature and somatostatin receptor scintigraphy.
ACCESSION #
109940297

 

Related Articles

  • Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. Sunday, Mary E; Haley, Kathleen J; Sikorski, Kristan; Graham, Sherry A; Emanuel, Rodica L; Zhang, Fan; Mu, QiQi; Shahsafaei, Aliakbar; Hatzis, Dimitrios // Oncogene;7/29/99, Vol. 18 Issue 30, p4336 

    We initiated a transgenic model for primary pulmonary neuroendocrine cell (PNEC) hyperplasia/neoplasia using v-Ha-ras driven by the neural/neuroendocrine (NE)-specific calcitonin promoter (rascal). Previously, we showed that nitrosamine treated rodents develop PNEC hyperplasia but non-NE lung...

  • Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract. R Jain // Journal of Clinical Pathology;Jul2009, Vol. 62 Issue 7, p634 

    BACKGROUND AND AIMS: Sinonasal intestinal-type adenocarcinomas (ITACs) are rare neoplasms resembling intestinal adenocarcinomas. Although several studies have documented neuroendocrine differentiation in ITACs, the combination of ITAC and small cell carcinoma has not been previously described in...

  • Neuroendocrine differentiation in sporadic CRC and hereditary nonpolyosis colorectal cancer. Sun, M. H. // Disease Markers;2004, Vol. 20 Issue 4/5, p283 

    Extent neuroendocrine differentiation can be encountered in many human neoplasm derived from different organs and systems using immunohistochemistry and ultrastructural techniques. The tumor cells' behaviors resemble those of neurons and neuroendocrine cells. The presence of neuroendocrine...

  • Research: ARMAIZ-PENA and COLLEAGUES.  // Positive Health;Dec2009, Issue 165, p1 

    An abstract of the study "Neuroendocrine Modulation of Cancer Progression," by G. N. Armaiz-Pena and colleagues is presented.

  • Cancer de prostată cu diferenÅ£iere neuroendocrină. Prezentare de caz. Glück, G.; Mihai, Mihaela; Stoica, R. // Romanian Journal of Urology;Mar2011, Vol. 10 Issue 1, p51 

    Introduction. About 95% of prostate cancers are adenocarcinoamas. Depending on the detection method used, neuroendocrine cells (NE) are found in 10% to 100% of prostate cancer specimens. (1) Case presentation. Male patient I.M. was diagnosed in 2006 with adenocarcinoma of the prostate, PSA 4.1...

  • Gastric Carcinoids and Therapeutic Options. Case Report and Review of the Literature. Dobru, Daniela; Boeriu, Alina; Mocan, Simona; Pascarenco, Ofelia; Boeriu, Cristian; Molnar, Calin // Journal of Gastrointestinal & Liver Diseases;Mar2013, Vol. 22 Issue 1, p93 

    Neuroendocrine tumors (carcinoids) are tumors originating from neuroendocrine cells. The distinction between different types of gastric carcinoids is important for their management. We present the case of a 38-year old woman with type 1 gastric neuroendocrine tumors (NETs) associated with...

  • Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity. Nugent, Summer L.; Cunningham, Steven C.; Alexiev, Borislav A.; Bellavance, Emily; Papadimitriou, John C.; Hanna, Nader // Diagnostic Pathology;2007, Vol. 2, p43 

    Background: Mixed (composite) exocrine-neuroendocrine cell carcinomas are defined as an intimate admixture of neoplastic glandular exocrine and neuroendocrine cell types. Although gastric adenocarcinoma containing a small number of neuroendocrine cells is a relatively frequent occurrence,...

  • Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma. Sagnak, Levent; Topaloglu, Hikmet; Ozok, Ugur; Ersoy, Hamit // European Journal of Clinical & Medical Oncology;2011, Vol. 3 Issue 4, p84 

    Much progress has been made towards an understanding of the development and progression of prostate cancer (PC), and the factors which drive the development of androgen independence. Neuroendocrine (NE) cells may provide an intriguing link between NE cell differentiation (NED) and tumor...

  • NR4A2 Is Regulated by Gastrin and Influences Cellular Responses of Gastric Adenocarcinoma Cells. Misund, Kristine; Selvik, Linn-Karina Myrland; Rao, Shalini; Nørsett, Kristin; Bakke, Ingunn; Sandvik, Arne K.; Lægreid, Astrid; Bruland, Torunn; Prestvik, Wenche S.; Thommesen, Liv // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    The peptide hormone gastrin is known to play a role in differentiation, growth and apoptosis of cells in the gastric mucosa. In this study we demonstrate that gastrin induces Nuclear Receptor 4A2 (NR4A2) expression in the adenocarcinoma cell lines AR42J and AGS-GR, which both possess the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics